May 10 2024

April 5 2024

Elicio Therapeutics to Present Updated Clinical T Cell and Antigen Spreading Response Data from the Ongoing AMPLIFY-201 Phase 1 Study of ELI-002 and Preclinical Data on ELI-007 and ELI-008 at the AACR Annual Meeting

April 1 2024

Aardvark Therapeutics gearing up for $200 million IPO

February 22 2024

Off-the-shelf vaccine offers hope for pancreatic and colorectal cancer patients with KRAS mutations

February 15 2024

Hitchhiking cancer vaccine makes progress in the clinic

February 5 2024

Elicio Therapeutics Announces Publication Of Preclinical Data Demonstrating Power Of Amphiphile-Immunotherapy

April 11 2024

A Patient’s View: The impact Novel Vaccines May Have on Cancer Treatment

Chimeron Bio receives NIH (NCI) Innovative Concept Award for mRNA cancer vaccine development

May10 2024

Aardvark Therapeutics Announces $85 Million Oversubscribed Series C Financing

April 16 2024

Chimeron Bio receives NIH (NCI) Innovative Concept Award for mRNA cancer vaccine development